Robert P. Edwards

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.8Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Clinical Infectious Diseases(2022)10.1093/cid/ciac103

Top 6%

3.7DataRank

Top 6%115 citations

Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan +37 more

Papers

Driven by 29 papers — median percentile 92. Top paper: “Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)”.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Clinical Infectious Diseases(2022)10.1093/cid/ciac103

Top 6%

3.7DataRank

Top 6%115 citations

Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan +37 more

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

British Journal of Cancer(2020)10.1038/s41416-020-0900-0

Top 10%

2.1DataRank

Top 10%68 citations

Dominique‐Laurent Couturier, Anna Paterson, Anthony N. Karnezis, Christine Chow, Tayyebeh M. Nazeran +92 more

Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3659

N/A

1.7DataRank · unranked

34 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Journal of Clinical Oncology(2022)10.1200/jco.21.00656

N/A

0.848DataRank · unranked

23 citations

Susan M. Sereika, Lari Wenzel, Robert P. Edwards, Judith E. Knapp, Susan H. Hughes +13 more

Endometrial cancer risk factors in Singapore Chinese: a prospective cohort study

Annals of Epidemiology(2022)10.1016/j.annepidem.2022.04.002

N/A

0.529DataRank · unranked

33 citations

Shalkar Adambekov, Robert P. Edwards, Renwei Wang, Jian‐Min Yuan, Elora Kalix +3 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0

N/A

0.477DataRank · unranked

23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more

Association of neighborhood social vulnerability with ovarian cancer survival

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.10.030

N/A

0.312DataRank · unranked

7 citations

Esther Elishaev, Riyue Bao, Emily C. O’Brien, Kaitlyn Dinkins, Jessica Berger +17 more

Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1

Vaccines(2024)10.3390/vaccines12070777

N/A

0.292DataRank · unranked

6 citations

Kathleen M. Kokolus, Per Basse, J Filderman, Chloe E. Cosgrove, Simon C. Watkins +6 more

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1957

N/A

0.292DataRank · unranked

6 citations

Lucy Corthell, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Hye Sung Kim +10 more

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0061

N/A

0.292DataRank · unranked

6 citations

Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura, Cindy Sander +11 more

What the protein!? Computational methods for predicting microbial protein functions

OSF Preprints (OSF Preprints)(2023)10.31219/osf.io/jhmta

N/A

0DataRank · unranked

4 citations

Robert P. Edwards, Susanna R. Grigson

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5517

N/A

0DataRank · unranked

4 citations

Megan Othus, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Liam Il‐Young Chung +8 more

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells

Research Square(2023)10.21203/rs.3.rs-3399211/v1

N/A

0DataRank · unranked

1 citations

Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura +9 more

Data from PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment

(2023)10.1158/0008-5472.c.6503124.v1

N/A

0DataRank · unranked

0 citations

Ravikumar Muthuswamy, Kunle Odunsi, Robert P. Edwards, Paweł Kaliński, Nataša Obermajer

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676

N/A

0DataRank · unranked

0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676.v1

N/A

0DataRank · unranked

0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.014

N/A

0DataRank · unranked

5 citations

Lauren Borho, Esther Elishaev, Jessica Berger, M.M. Boisen, John T. Comerci +12 more

Medical comorbidities prognosticate survival in glioblastoma

BJC Reports(2025)10.1038/s44276-025-00189-4

N/A

0DataRank · unranked

1 citations

Jonathan Arditi, Julia Noreck, Robert P. Edwards, Jacob Kaiserman, Rainy Wortelboer +6 more

Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer

Disease Models & Mechanisms(2025)10.1242/dmm.052177

N/A

0DataRank · unranked

0 citations

Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange, Syed I. A. Zaidi +12 more

IFNγ-mediated suppression of alternative NF-κB in tumor-resident myeloid cells promotes selective recruitment of cytotoxic but not regulatory T cells

Frontiers in Immunology(2025)10.3389/fimmu.2025.1681777

N/A

0DataRank · unranked

0 citations

Ravikumar Muthuswamy, Bowen Dong, Robert P. Edwards, Paweł Kaliński, Adam S. Brinkman

Immunotherapy Advances for Epithelial Ovarian Cancer

Cancers(2020)10.3390/cancers12123733

N/A

0DataRank · unranked

39 citations

Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards, Anda Vlad +1 more

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

UNC Libraries(2020)10.17615/5jcw-ca69

N/A

0DataRank · unranked

0 citations

David S. Miller, Steven Waggoner, Robert P. Edwards, Saketh R. Guntupalli, Matthew A. Powell +13 more

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

UNC Libraries(2020)10.17615/g9e9-qj75

N/A

0DataRank · unranked

0 citations

Ramesh K. Ramanathan, Robert P. Edwards, William C. Zamboni, Yung‐Jue Bang

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

UNC Libraries(2020)10.17615/2xde-se42

N/A

0DataRank · unranked

0 citations

Phuong L. Mai, David S. Alberts, William J. Welch, Carol J. Fabian, Mary B. Daly +32 more

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

npj Precision Oncology(2021)10.1038/s41698-021-00242-8

N/A

0DataRank · unranked

56 citations

Ahmed Soliman, Amy Joehlin‐Price, Peter G. Rose, Anda Vlad, Robert P. Edwards +2 more

Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data

BMC Medicine(2022)10.1186/s12916-022-02532-9

N/A

0DataRank · unranked

26 citations

Claire Levy, Ronit Katz, Erica M. Lokken, Melis N. Anahtar, Melissa Barousse Hall +95 more

Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101080

N/A

0DataRank · unranked

13 citations

Alyssa Wield, Brigid Mumford, Isabel Janmey, Li Wang, Philip J. Grosse +13 more

Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy

Cancers(2022)10.3390/cancers14225647

N/A

0DataRank · unranked

5 citations

Mary Strange, Yusi Fang, Ibrahim Uygun, Lixin Zhang, George C. Tseng +4 more

Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2254

N/A

0DataRank · unranked

25 citations

Santiago Panesso-Gómez, Jaynish S. Shah, Tonge Ebai, Qi Jiang, Ece Gümüşoğlu-Acar +6 more

Robert P. Edwards

Indexed papers

Top data-sharing exemplar

Papers